Ownership history in STRS OHIO · 10 quarters on record
This page tracks every 13F SEC filing in which STRS OHIO reported a position in CELLDEX THERAPEUTICS INC (CLDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,900 | -3,700 | -56.1% | 0.00% | $75K | $25.87 |
| 2024 Q2 | ADDED | 6,600 | +700 | +11.9% | 0.00% | $244K | $37.01 |
| 2024 Q1 | ADDED | 5,900 | +3,200 | +118.5% | 0.00% | $247K | $41.97 |
| 2023 Q4 | ADDED | 2,700 | +1,300 | +92.9% | 0.00% | $107K | $39.66 |
As of 2025 Q4 — sorted by position size